Great Novel Therapeutics Biotech & Medicals (TPEX:7427)

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018
Cancer Medical Treatment	4.85M	Log In	Log In	Log In
Cancer Medical Treatment Growth	798.15%	Log In	Log In	Log In
Other	-	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018
Taiwan	4.85M	Log In	Log In	Log In
Taiwan Growth	798.15%	Log In	Log In	Log In